2026-02-24T12:03:29-06:00 2024-12-31 135565207 KPMG LLP 8350 BROAD STREET SUITE 900 MCLEAN VA 22101 990 2024-01-01 823285540 COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS US COAL 2028000220 1901 PENNSYLVANIA AVENUE NW 1003 WASHINGTON DC 200063405 NICOLE LURIE PRESIDENT 2028000220 2026-02-24 1 0 BRIAN KEARNS P02061479 7032868000 2026-02-23 2024 2025-03-06 01:10:19Z X NICOLE LURIE 1901 PENNSYLVANIA AVENUE NW 1003 WASHINGTON DC 200063405 9806388 0 X CEPI.NET X 2017 DC CEPI US IS A REGISTERED NON-PROFIT CORPORATION THAT SUPPORTS SOCIAL WELFARE (SEE SCH O) IN ACCORDANCE WITH SECTION 501(C)(4) OF THE US INTERNAL REVENUE CODE OF 1986. IN FURTHERANCE OF SUCH PURPOSES, CEPI US SHALL ENGAGE ACTIVITIES PROMOTING THE OBJECTIVES OF COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI), AN INTERNATIONAL NON-PROFIT ORGANIZATION FORMED TO WORK TOWARDS A WORLD IN WHICH EPIDEMICS AND PANDEMICS ARE NO LONGER A THREAT TO HUMANITY, BY ACCELERATING THE DEVELOPMENT, MANUFACTURE AND STOCKPILING OF VACCINES AND SELECT BIOLOGICALS NECESSARY TO RESPOND TO EMERGING INFECTIOUS DISEASES FOR WHICH THERE IS MARKET FAILURE, OR NO COMMERCIAL MARKETS EXIST. 3 0 49 0 0 0 6499849 9670823 0 0 94409 135565 0 0 6594258 9806388 0 0 0 0 5905222 8899813 0 0 0 689036 906575 6594258 9806388 0 0 3740346 4611016 3740346 4611016 0 0 X COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS US ("CEPI US") WAS ORGANIZED FOR SEVERAL PURPOSES:(1) TO EDUCATE THE AMERICAN PUBLIC ABOUT THE IMPORTANCE OF DEVELOPING VACCINES TO COMBAT FUTURE GLOBAL EPIDEMICS (SEE SCHEDULE O)AND CEPI'S GOALS OF COORDINATING THE DEVELOPMENT OF SUCH VACCINES;(2) TO COORDINATE THE EFFORTS OF CEPI'S PARTNERS THAT ARE LOCATED IN THE US, INCLUDING PRIVATE FOUNDATIONS, INDUSTRY, TRADE ASSOCIATIONS, ACADEMIC AND RESEARCH INSTITUTIONS, AND OTHER NOT-FOR-PROFITS; AND,(3) TO ADVOCATE FOR SUPPORT, INCLUDING POTENTIAL FUNDING FOR CEPI US BY THE U.S. GOVERNMENT. 0 0 9752148 IN A WORLD CHARACTERIZED BY INCREASING POPULATION DENSITY, HUMAN MOBILITY, AND ECOLOGICAL CHANGE, EMERGING INFECTIOUS DISEASES POSE A REAL AND GROWING THREAT TO GLOBAL HEALTH SECURITY. EPIDEMIC DISEASES AFFECT EVERYBODY, AND DO NOT RESPECT BORDERS. VACCINES ARE ONE OF THEMOST POWERFUL TOOLS IN THE FIGHT TO OUTSMART EPIDEMICS. CEPI US'S MISSION IS TO STIMULATE AND ACCELERATE THE DEVELOPMENT OF VACCINES AGAINST EMERGING INFECTIOUS DISEASES AND ENABLE EQUITABLE ACCESS TO THESE VACCINES FOR AFFECTED POPULATIONS DURING OUTBREAKS. CEPI IS AN INNOVATIVE GLOBAL COALITION OF PUBLIC, PRIVATE, PHILANTHROPIC, AND CIVIL SOCIETY ORGANIZATIONS, WITH WHOM WE WORK IN PARTNERSHIP. CLOSE COLLABORATION WITH GLOBAL PARTNERS WILL BE CRUCIAL TO THE SUCCESS OF CEPIS WORK TO DEVELOP VACCINES AGAINST EMERGING (SEE SCHEDULE O) INFECTIOUS DISEASES. THEREFORE, CEPI WILL SUPPORT COORDINATING ACTIVITIES TO IMPROVE OUR COLLECTIVE RESPONSE TO EPIDEMICS, STRENGTHENING CAPACITY IN COUNTRIES AT RISK, AND ADVANCING THE REGULATORY SCIENCE THAT GOVERNS PRODUCT DEVELOPMENT. 9752148 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 49 1 0 0 0 0 0 0 0 0 0 0 0 0 X 3 0 0 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 0 1 1 0 X NICOLE LURIE 2028000220 1901 PENNSYLVANIA AVENUE NW SUITE WASHINGTON DC 200063405 RICHARD HATCHETT DIRECTOR, CEO 2.00 40.00 X X 0 882841 0 NICOLE LURIE DIRECTOR, PRESIDENT 40.00 0.00 X X 307456 0 27384 MADS HOGHOLEN DIRECTOR, TREASURER 1.00 40.00 X X 0 142937 0 MONINA VIERNEZA SECRETARY 1.00 40.00 X 0 147488 0 DANIELLE CRAIG REGULATORY AFFAIRS LEAD AM 40.00 0.00 X 262434 0 71116 CHRISTOPHER T DA COSTA PROJECT LEADER, R&D 40.00 0.00 X 271877 0 53946 CATHERINE HOATH REGULATORY AFFAIRS STRATEGY LEAD 40.00 0.00 X 260893 0 63810 REBECCA FARKAS HEAD OF TECHNOLOGY 40.00 0.00 X 252581 0 70749 ANDREW HEBBELER DIRECTOR OF BIOSECURITY 40.00 0.00 X 263575 0 48179 1618816 1173266 335184 34 0 1 0 0 9670823 9670823 135565 135565 9806388 0 0 135565 334840 334840 7063764 7063764 560094 560094 431839 431839 509276 509276 9452 9452 44788 44788 58609 58609 159701 159701 10622 10622 378165 378165 138825 138825 37764 37764 19709 19709 7647 7647 OTHER EXPENSES 28764 28764 MEMBERSHIP DUES 7500 7500 ENTERTAINMENT 5029 5029 9806388 9752148 54240 0 3585245 4404912 34449 105162 160054 59112 120652 100942 3740346 4611016 3740346 4611016 3740346 4611016 X 0 0 3740346 4611016 0 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 160054 59112 100942 100942 X X X 0 0 0 0 0 0 0 0 0 RICHARD HATCHETT DIRECTOR, CEO 0 579080 0 301777 0 1984 0 0 0 0 0 882841 0 0 NICOLE LURIE DIRECTOR, PRESIDENT 307456 0 0 0 0 0 24596 0 2788 0 334840 0 0 0 DANIELLE CRAIG REGULATORY AFFAIRS LEAD AM 262434 0 0 0 0 0 44749 0 26367 0 333550 0 0 0 CHRISTOPHER T DA COSTA PROJECT LEADER, R&D 271877 0 0 0 0 0 51150 0 2796 0 325823 0 0 0 CATHERINE HOATH REGULATORY AFFAIRS STRATEGY LEAD 260893 0 0 0 0 0 42200 0 21610 0 324703 0 0 0 REBECCA FARKAS HEAD OF TECHNOLOGY 252581 0 0 0 0 0 39887 0 30862 0 323330 0 0 0 ANDREW HEBBELER DIRECTOR OF BIOSECURITY 263575 0 0 0 0 0 27742 0 20437 0 311754 0 0 0 FORM 990, PART I, BOX B: REASON FOR AMENDING RETURN THE 2024 FORM 990 IS BEING AMENDED TO CORRECT THE REPORTABLE COMPENSATION FOR AN INDIVIDUAL REPORTED ON PART VII. FORM 990, PART VI, SECTION A, LINE 7A COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS, THE CORPORATION'S FOUNDER, HAS THE RIGHT TO APPOINT, REMOVE AND REPLACE THE DIRECTORS OF THE CORPORATION. FORM 990, PART VI, SECTION A, LINE 7B THE ARTICLES OF INCORPORATION AND BYLAWS OF THE CORPORATION MAY BE AMENDED ONLY WITH THE WRITTEN CONSENT OF THE CORPORATION'S FOUNDER, COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION DID CONTEMPORANEOUSLY DOCUMENT THE MEETINGS HELD OR WRITTEN ACTIONS UNDERTAKEN DURING THE YEAR BY ITS BOARD OF DIRECTORS. THE BOARD OF DIRECTORS HAS NO COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11B CEPI MANAGEMENT WORKS WITH AN OUTSIDE ACCOUNTING FIRM TO PREPARE FORM 990. ONCE PREPARED, OPERATIONAL LEADERSHIP REVIEWS AND APPROVES THE ENTIRE FORM 990 PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C CEPI US HAS ADOPTED THE CONFLICT-OF-INTEREST POLICY AND PROCEDURES OF ITS FOUNDER, THE COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS. CEPI US EMPLOYEES ARE THEREFORE SUBJECT TO THIS POLICY. CEPI US TYPICALLY REQUESTS ITS EMPLOYEES TO COMPLETE ITS STANDARD DECLARATION OF INTEREST FORM AND WHERE INTERESTS ARE DISCLOSED, THE CORPORATION CARRYS OUT AN ASSESSMENT OF THOSE AND TAKES ANY NECESSARY MEASURES TO APPROPRIATELY MANAGE SUCH DECLARED INTERESTS. IN ADDITION, THERE IS CURRENTLY WORK IN PROGRESS TO ESTABLISH A CENTRAL SYSTEM FOR SUBMITTING SUCH DECLARATIONS OF INTERESTS OF BOTH EMPLOYEES AND EXTERNAL PARTNERS AS WELL AS TO OPTIMIZE OUR FRAMEWORK FOR REVIEW AND MONITORING OF DECLARED INTERESTS. FORM 990, PART VI, SECTION B, LINE 15 FOR THE TOP INDIVIDUAL OR INDIVIDUALS WITH ULTIMATE RESPONSIBILITY FOR IMPLEMENTING THE DECISIONS OF CEPI US'S BOARD OF DIRECTORS, AS WELL AS OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION, CEPI US IMPLEMENTS REVIEW AND APPROVAL OF COMPENSATION BY INDEPENDENT PERSONS USING COMPARABILITY DATA. THE APPROVING BODY MUST CONCURRENTLY DOCUMENT HOW IT REACHED ITS DECISIONS, INCLUDING THE DATA ON WHICH IT RELIED. THE APPROVAL OF COMPENSATION IS DOCUMENTED IN A COMMITTEE OF THE CEPI NORWAY BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS ARTICLES OF INCORPORATION, CONFLICT OF INTEREST POLICY, AND GROUP FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC VIA THE ORGANIZATION'S WEBSITE. CEPI NORWAY SKOYEN ATRIUM ASKEKROKEN 11 OSLO NO 0277 981407955 INTERNATIONAL HEALTH NO FOREIGN N/A 0 CEPI UK HENRY WOOD HOUSE 4-5 LANGHAM PLACE LONDON UK W1B 3DG 981699526 INTERNATIONAL HEALTH UK FOREIGN CEPI NORWAY 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CEPI NORWAY C 9670823 FAIR MARKET VALUE